CTRI/2022/05/042769Completed未知
Evaluating The Efficacy OF Trans-Resveratrol in Extraction Socket Of Impacted Mandibular Third Molar - DOUBLE BLIND STUDY
Gunti Natraj0 sites5 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 5
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Patients with hemodynamically stable, ASA class I .
- •Patients in the age group of 20-40 years .
- •Patients undergoing extraction for mandibular impaction.
- •Patients with no known history of adverse reactions to anti-inflammatory drugs.
Exclusion Criteria
- •Patients under the age of 20 years and above the age of 40 years.
- •Patients undergoing maxillary impaction.
Investigators
Similar Trials
Completed
Phase 3
Evaluation of the effects of resveratrol in patients with Covid ??Covid-19.COVID-19, virus identifiedIRCT20111119008129N13Boushehr University of Medical Sciences140
Completed
Phase 3
Investigating the effect of resveratrol on polycystic ovary syndromePolycystic ovary syndrome.Polycystic ovary syndromeE28.2IRCT20221106056417N1Tehran University of Medical Sciences56
Recruiting
Phase 3
Resveratrol in COVID19IRCT20200112046089N1Ahvaz University of Medical Sciences50
Recruiting
Phase 3
The effect of resveratrol on strokeIschemic stroke.Other cerebrovascular diseasesIRCT20191020045162N1Kermanshah University of Medical Sciences60
Completed
Phase 2
Evaluation of the effects of Resveratrol Supplementation on Hepatic Enzymes, Inflammatory Factors, Lipid profile, blood glucose, Insulin Sensitivity, and Hepatic fibrosis in patients with Nonalcoholic Fatty Liver Disease.on Alcoholic Fatty Liver.Inflammatory liver disease, unspecifiedIRCT201202014010N7ational Nutrition and Food Technology Research Institute50